Learning Objectives:

1.    Review the NCCN guidelines for early prostate cancer detection and very low/low-risk prostate cancer
2.    Review the role of molecular biomarkers in the evaluation of patients with prostate cancer and how they guide treatment decisions
3.    Discuss the rationale and limitations of molecular biomarkers in prostate cancer evaluation

Faculty Disclosure:

Shaun Wason, MD, Presenter has no relevant financial relationships to disclose.

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.